NOF Corporation
Notice Regarding Revision of Consolidated Earnings Forecast for the Fiscal Year Ending March 2027 and Revision of Retained Earnings Distribution (Interim Dividend) and Year-end Dividend Forecast
Revised the consolidated earnings forecast announced on May 11, 2026 to revenue of 321,500 million yen, operating income of 50,500 million yen, ordinary income of 51,800 million yen, and net income attributable to owners of parent of 41,000 million yen. Increase compared to the interim period; foreign exchange assumptions revised to USD/JPY 158 and EUR/JPY 182. Interim dividend raised to 37 yen, year-end dividend to 37 yen, resulting in an annual dividend of 74 yen.
Key Figures
- Revenue: 321,500 million yen
- Operating Income: 50,500 million yen
- Ordinary Income: 51,800 million yen
AI要約
Revision of Earnings Forecast and Background
At the board of directors meeting held today, we revised the full-year consolidated earnings forecast based on results through the second quarter of fiscal 2026 and outlook from the third quarter onward. Functional chemicals are expected to show firm demand with limited variability, while pharmaceuticals/medical/health and chemical products are shipping launched products as planned but are affected by delays in shipments of developmental products. Food-related businesses are expected to be impacted by rising raw material costs and demand shifts. Overall, the company is expected to exceed the previous forecast. Foreign exchange assumptions have been revised to USD/JPY 158 and EUR/JPY 182.
Dividend Policy and Shareholder Returns
The interim dividend has been revised to 37 yen and the year-end dividend to 37 yen, raising the annual dividend to 74 yen. The interim dividend will be paid from retained earnings, and the company will continue to pursue enhancement of corporate value while proactively implementing share buybacks and cancellations as needed.
NOF Corporation
Company overview · Stock price · Financial data · All IR
